Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
10:13:00 EDT Tue 30 Apr 2024
Enter Symbol
or Name
USA
CA



Q:CRMD - CORMEDIX INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CRMD - Q0.25.29·5.300.15.295+0.0150.323.91161565.23  5.31  5.187.00  2.5709:52:53Apr 1915 min RT 2¢

Recent Trades - Last 10 of 156
Time ETExPriceChangeVolume
09:52:53Q5.29020.010224
09:52:53Q5.29020.01021
09:52:53Q5.29070.01071
09:52:11Q5.300.0284
09:52:05Q5.300.0216
09:52:05Q5.29550.015516
09:51:49Q5.300.0234
09:50:55Q5.2950.015100
09:50:11Q5.310.03100
09:50:11Q5.300.02100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-19 08:30U:CRMDNews ReleaseCorMedix Inc. Announces CMS Grants TDAPA to DefenCath
2024-04-15 08:30U:CRMDNews ReleaseCorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath(TM) (Taurolidine and Heparin)
2024-04-11 08:30U:CRMDNews ReleaseCorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference
2024-04-08 08:30U:CRMDNews ReleaseCorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC
2024-03-27 08:30U:CRMDNews ReleaseCorMedix Inc. to Present at the Needham Annual Healthcare Conference
2024-03-12 07:30U:CRMDNews ReleaseCorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
2024-03-06 08:30U:CRMDNews ReleaseCorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024
2024-01-30 08:30U:CRMDNews ReleaseCorMedix Inc. Announces Commercial and Reimbursement Updates
2024-01-08 08:30U:CRMDNews ReleaseCorMedix Inc. Announces Commercial and Operational Updates
2023-12-15 08:30U:CRMDNews ReleaseCorMedix Inc. Announces Appointment of Chief Legal Officer
2023-12-04 08:30U:CRMDNews ReleaseCorMedix Inc. Announces Partnership With The Leapfrog Group
2023-11-15 12:58U:CRMDNews ReleaseCorMedix Inc. Announces FDA Approval of DefenCath ‚ ® to Reduce the Incidence of Catheter-Related Bloodstream Infections in Adult Hemodialysis Patients
2023-11-14 16:05U:CRMDNews ReleaseCorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Update
2023-11-02 08:30U:CRMDNews ReleaseCorMedix Inc. to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on November 14, 2023
2023-10-11 08:30U:CRMDNews ReleaseCorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek Conference
2023-09-26 08:30U:CRMDNews ReleaseCorMedix Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
2023-09-08 08:30U:CRMDNews ReleaseCorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of Nephrology
2023-09-06 08:30U:CRMDNews ReleaseCorMedix Inc. to Present at the H.C. Wainwright Annual Global Investment Conference
2023-08-30 08:00U:CRMDNews ReleaseCorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product Defencath
2023-08-08 07:30U:CRMDNews ReleaseCorMedix Inc. Reports Second Quarter and Six Month 2023 Financial Results and Provides Business Update